ABO-101

· Arbor Biotechnologies

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABO-101, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine) [Phase 1, Phase 2]